Pediatric Pulmonology

Author Guidelines

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

No material published in Pediatric Pulmonology may be reproduced or published elsewhere without the written permission of the publisher and the author.

To request permission to reproduce an article, in part, or in whole, click here to for the Permissions Page

Author Guidelines

For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.

Click here for Online Manuscript Submission

Scope of the Journal

Pediatric Pulmonology publishes state of the art reviews, editorials, the results of original clinical or laboratory research, exceptionally instructive or unique case reports, and letters to the Editor pertaining to pediatric pulmonology. Reports on meetings, conferences and symposia may be published after consultation with the Publisher and the Editor-in-Chief. Preliminary brief communications will be considered only if they contain information that can be considered a major breakthrough. The length of original articles is not limited but the author(s) should be aware that very long manuscripts are more difficult to publish owing to space limitations, case reports should be concise ( a maximum of 3 typewritten pages excluding references) and contain a maximum of two figures and or tables. Authorship of case reports shall be limited to three unless the role of each co-author is carefully justified in a separate letter to the editor. The Editors reserve the right to return any manuscript that is not in acceptable English. Translations from another language will not be provided by the Editorial Office. Note that in accord with other leading respiratory journals, we do not publish research funded by tobacco companies.

Submission of Manuscripts

Go to http://mc.manuscriptcentral.com/ppul and login to your account. If you do not have an account, click on "Register Here" to establish one.

Please note a signed Copyright Transfer Agreement form is required upon submission. The submitting author's signature is all that is required at the time of submission, however, should the manuscript be accepted for publication, ALL co-authors will be required to sign the Copyright Transfer Agreement.

Click here to access the Copyright Transfer Agreement

Manuscripts submitted to Pediatric Pulmonology may not have been published in any part or form in another publication of any type, professional or lay, including electronic publications.

Authors are also required to provide information about possible conflicts of interest with the subject of the manuscript; the existence of such does not automatically preclude publication (see further information below).

All statements in, or omissions from, published manuscripts are the responsibility of the authors who are asked to carefully review proofs prior to publication.

Prepare the text and illustrations according to the instructions found below. You may enter and exit the manuscript submission process at the completion of each step, and you may leave an unfinished draft in the system and continue work on it later. However, once you submit your manuscript you will not be able to edit it. If you have any questions about this process please contact us at edsupport@wiley.com

English Language Services

We suggest that authors from non English- speaking countries have their manuscript reviewed and corrected by English Language Services before submission. To read more about our policy and see a list of editing services, go here: http://blackwellpublishing.com/bauthor/english_language.asp

Conflict of Interest

Authors must indicate at the time of submission of research papers any potential conflict of interest particularly of a fiscal nature that may have a perceived influence on the results of the research. A conflict of interest statement should appear in the Acknowledgment section. For further information on Uniform Requirements for Scientific manuscripts and Conflict of Interest please refer to: International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts submitted to Biomedical Journals. Ann Intern Med 1997;126:36-47. The complete text of the document can also be found online at www.icmje.org

Experimental and Publication Ethics

Studies involving human subjects must conform to the guiding principles of the World Medical Association Declaration of Helsinki: www.wma.net/e/policy/b3.htm. Human subjects must have given informed consent and the study must have been approved by the Committee on Human Research at the author(s) institution(s) and a statement to this effect must appear in the Methods section of the submitted article. It is also important to document in the Methods section that consent has been obtained from older children and adolescents. Similarly, animal studies must be approved by an Institutional Animal Research Review Board and a statement to this effect must appear in the Methods section. In addition, details of anesthesia and euthanasia must appear in the Methods section.

We recognize the importance of developing the highest ethical standards and we are committed to ethical publication practice. For more information on the publisher’s policies, please see Wiley-Blackwell Guidelines on Publication Ethics and Best Practices at www.wiley.com/bw/publicationethics. Of particular importance is the section on Research Misconduct, which includes data fabrication, falsification, plagiarism, and inappropriate image manipulation.

It should be noted that Pediatric Pulmonology employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Prior Publication

Pediatric Pulmonology will only publish original articles that contain material that has not been previously published or is currently submitted for publication elsewhere, with the exception of abstracts containing no more than 400 words. Any material available via PubMed or other electronic sources is considered to have been published. When a question arises, the Editor-in-Chief will determine what constitutes duplicate publication.

It is the responsibility of submitting authors to inform the Editor-in-Chief of potentially overlapping or related data either in submitted manuscripts or papers in press, and such manuscripts should be appended to the submission. If there is significant overlap in data with previously published articles this should be addressed by the author in the “Authors Comments” section during the submission process. In particular, giving reasons why the new submission should be published. Again, the editors reserve the right to determine whether or not another publication is warranted.

For further information on redundant or duplicate publication, please see “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” at http://www.icmje.org/index.htm

Components of Articles

Authors should include the following in their manuscripts:

1. a summary of the article including rationale for the study, methods, results, and conclusions,
2. an introductory statement about the specific aims of the study and a discussion of how each aim was fulfilled;
3. a succinct description of the working hypothesis;
4. a detailed explanation of assumptions and choices made regarding study design and methodology; readers should be given precise information about what has been done, by what means, and how the choice of methodology might have influenced the results;
5. a description of the reasons for choosing the type and number of experimental subjects (patients, animals, controls) and individual measurements; if applicable, information about how and why the numbers may differ from an ideal design (e.g., the number required for achieving 90% confidence in eliminating Type II error);
6. specifics about statistical principles, techniques and calculations employed and, if applicable, methods for rejecting the null hypothesis;
7. a concise comparison of the results with those of conflicting or confirmatory studies in the literature;
8. a critical selection of up to date references from the world literature with relevance to scientific background, methodology, assumptions, interpretation of the results and conclusions.

The availability of the above information facilitates the assessment of manuscripts, but by itself is not a decisive criterion of acceptance.

Wiley's Journal Styles Are Now in EndNote

EndNote is a software product that we recommend to our journal authors to help simplify and streamline the research process. Using EndNote's bibliographic management tools, you can search bibliographic databases, build and organize your reference collection, and then instantly output your bibliography in any Wiley journal style.
Download Reference Style for this Journal: If you already use EndNote, you can download the reference style for this journal.
How to Order: To learn more about EndNote, or to purchase your own copy, click here.
Technical Support: If you need assistance using EndNote, contact endnote@isiresearchsoft.com, or visit www.endnote.com/support.

Clinical Trials

We endorse the Consolidated Statement of Reporting Trials (CONSORT Statement) Lancet 2002;357:1191-1194 which may be accessed at www.consort-statement.org . In accordance with ICMJE standards, all clinical trials must be registered with a database that is publicly accessible such as http://clinicaltrials.gov/   However, other free of charge public registries are acceptable. For further information, please visit http://www.icmje.org/index.htm#clin_trials

Peer Review

Authors are encouraged to submit names of expert(s) who they deem appropriate to review their paper. Authors may also indicate persons to whom they do not wish the manuscript sent for review. In most cases, articles will be   reviewed by at least two or more authorities as well as the editorial staff to determine validity, significance, and originality of contents and conclusions. The reviewers will be selected by the Editor-in-Chief, Associate Editors, and/or Editorial Board members. The selection will be made on the basis of expertise, impartiality, and equal distribution among the available experts, regardless of geographic origin of the manuscript or locations of the reviewers. . Authors will be advised within the shortest possible time whether their paper is accepted, requires major or minor revisions, or is rejected All necessary efforts will be made to ensure a speedy review process. The time from submission to final decision can be shortened by a timely return of a revised manuscript when revision has been requested. The Editor-in-Chief reserves the right to reject any submission deemed not suitable for the journal after an in-house review.

CrossCheck is a multi-publisher initiative to screen published and submitted content for originality. Pediatric Pulmonology uses iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. To find out more about CrossCheck visit http://www.crossref.org/crosscheck.html.

Fast-Track Review

If circumstances so warrant, a fast-track review of a paper may be requested in the cover letter. At the Editor-in-Chief’s discretion, a fast-track review will be undertaken to expedite manuscripts that deserve rapid review and publication. Expedited peer review and publication is rare and is reserved for timely presentation of significant data. If fast-track review is requested in the cover letter, the corresponding author will be informed if expedited review has been granted or not.

Submissions From Editors

Pediatric Pulmonology strives to ensure that any submission from the Editor-in-Chief, Deputy and Associate Editors, or from a member of the journal’s Editorial Board receives an objective and unbiased evaluation. This is achieved by assigning any research article submitted by the Editor-in-Chief,Deputy or Associate Editors to an impartial referree who can maintain the integrity of the review process. When appropriate, Pediatric Pulmonology may also utilizes the services of Guest Editors who are members of the Editorial Board and familiar with the peer review processes and policies of the journal. Articles submitted by Editorial board members undergo a blinded peer review process that is as stringent as for those authors who are not on the editorial board. All submitting authors are automatically blinded to all aspects of the review process by ScholarOne Manuscripts.

Preparation of Manuscripts

Standard, double-spaced manuscript format is requested.

Title page. The title should be brief(no more than 100 characters in length including spaces) and useful for indexing. All authors' names with highest academic degree, affiliation of each, but no position or rank, should be listed. For cooperative studies, the institution where research was primarily done should be indicated. In a separate paragraph, specify grants, other financial support received, and the granting institutions. If support from manufacturers of products used is listed, assurances about the absence of bias by the sponsor and principal author must be given. Identify meeting, if any, at which the paper was presented. The name, complete mailing address, Telephone number, Fax number, and E- mail address of the person to whom correspondence and requests for reprints are to be sent must be included.

Abbreviated title. For usage as a running head, provide the essence of the title (maximum 50 characters) on the bottom of the Title page.

Summary. In accordance with the structure of the article, with or without separate headings, outline the objectives, working hypothesis, study design, patient-subject selection, methodology, results (including numerical findings) and conclusions. The Summary should not exceed one double-spaced page. If abbreviations are used several times, spell out the words followed by the abbreviations in parentheses. Other than English, language summaries are not required.

Keywords. Supply a minimum of 3 to 5 keywords, exclusive of words in the title of the manuscript. A guide to medical subject heading terms used by PubMed is available at http://www.nlm.nih.gov/mesh/MBrowser.html  

Abbreviations. Define abbreviations when they first occur in the manuscript and from there on use only the abbreviation. Whenever standardized abbreviations are available use those. Use standard symbols with subscripts and superscripts in their proper place.

Drug names. Use generic names. If identification of a brand name is required, insert it in parentheses together with the manufacturer's name and address after the first mention of the generic name.

Text. Start text on a new page and number all pages (including Tables and Legends) consecutively. Divide article into: Introduction, Materials and Methods, Results, and Discussion, starting each part on a new page. All methodology and description of experimental subjects should be under Materials and Methods; results should not be included in the Introduction.

Acknowledgments. Technical assistance, advice, referral of patients, etc. may be briefly acknowledged at the end of the text.

References.

References should be prepared according to CBE style. Refer to the CBE Style Manual, 6th edition (Cambridge University Press). Start the listing on a new page, double-spaced throughout. Number the references in the sequence in which they first appear in the text, listing each only once even though it may be cited repeatedly. Journals' names should be shown by their abbreviated title in Index Medicus .

Manuscripts in preparation or submitted for publication are not acceptable references. If a manuscript "in press" is used as a reference, a copy of it must be provided at the time of submission of the manuscript.

Sample references:

Standard journal article
Landau IL, Morgan W, McCoy KS, Taussig LM. Gender related differences in airway tone in children. Pediatr Pulmonol 1993;16:31-35. (Include names of all authors, and first and last page numbers with all digits.)

Book with authors
Voet D, Voet JG. 1990. Biochemistry. New York: John Wiley & Sons. 1223 p.

Book with editors
Coutinho A, Kazatch Kine MD, editors. Autoimmunity physiology and disease. New York. Wiley-Liss; 1994. 459 p.

Chapter in a Book
Hausdorf G. Late effects of anthracycline therapy in childhood: evaluation and current therapy. In: Bricker JT, Green DM, D'Angio GJ, editors. Cardiac toxicology after treatment for childhood cancer. New York: Wiley-Liss; 1993. p 73-86.

For a book reference include the page numbers that have direct bearing on the work described.

Tables. Number tables with Arabic numbers consecutively and in order of appearance. Type each table double-spaced on a separate page, captions typed above the tabular material. Symbols for units should be used only in column headings. Do not use internal horizontal or vertical lines; place horizontal lines between table caption and column heading, under column headings, and at the bottom of the table (above the footnotes if any). Use footnote letters (a, b, c, etc.) in consistent order in each table. All tables should be referred to in the text. Do not submit tables as photographs and do not separate legends from tables.

Illustrations. Illustration files must be in TIF or EPS (with preview) formats . Number illustrations with Arabic numbers and refer to each figure in the text. The preferred form is 5 X 7 inches (12.5 X 17.5 cm). Print reproduction requires files for full color images to be in a CMYK color space. See author charges below.

Journal quality reproduction will require grey scale and color files at resolutions yielding approximately 300 ppi. Bitmapped line art should be submitted at resolutions yielding 600-1200 ppi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly.

Lettering on illustrations should be of a size and weight appropriate to the content and the clarity of printing must allow for legibility after reduction to final size. Labeling and arrows on illustrations must be done professionally. Spelling, abbreviations, and symbols should precisely correspond to those used in the text. Indicate the stain and magnification of each photomicrograph. Photographs of recognizable subjects must be accompanied by signed consent of the subject of publication. Illustrations previously published must be accompanied by the author's and publisher's permission.

Figure Legends for the illustrations should be brief, and included on a separate page under the heading: "Figure Legends." When borrowed material is used, the source of the illustration should be shown in parentheses after its legend, either by a reference number or in full if not listed under References.

Informed consent statements, if applicable, should be included in the Methods section.

Online Data Supplements. Additional material such as text, tables, figures, video and soundtrack files may be submitted for posting on the online data supplement of Pediatric Pulmonology . The material should be submitted simultaneously with the main manuscript and will be peer reviewed at the same time. Note that tables, figures, and reference numbers for an electronic supplement should be preceded by the letter “E.: For example “E-table 1,” E-references,” “E-figure 1,” etc.

Letters to the Editor. Letters may offer criticism of published material in an objective, constructive, and educational manner inducive of further debate. Letters may also discuss matters of general interest pertaining to the general field of pediatric pulmonology in the broadest sense. Letters must be double-spaced, short, with few references, a small table, or an illustration. If acceptable, a copy will be sent to the author(s) referred to in the letter, giving the opportunity to provide a rebuttal for publication with the letter.  Letters may also consist of brief case reports of truly unique cases. Note that we do not publish original, unpublished data as letters.

Editorials. Editorial officers and Board members may make editorial comments on individual articles or on a group of articles published in the same issue or may ask individuals to write editorials. However, anyone interested in writing editorial-type commentaries is invited to do so.

Case Reports. Only highly unique and instructive case reports will be considered for publication. These should be limited to 1000 words and contain only one figure or table, and be preceded by a 2 to 3 sentence summary.

Author charges. Printing costs of color illustrations will be charged to the author. The Editor-in-Chief has the discretion to wave the color charges.

Proofs. Upon acceptance, a set of galley proofs will be e-mailed to the corresponding author and should be returned within 48 hours of receipt. Alterations should be kept to a minimum. Costs of extensive alterations to the galley proof will be billed to the authors. Reprints may be ordered by using the reprint order form that accompanies proofs. Orders placed after publication cannot be filled at the regular rates.

The National Institutes of Health Public Access Initiative . If any of the authors of a submitted manuscript have been funded by the NIH for the research reported in the article, the grant number and contact name should be indicated on the title page. The publisher will forward an electronic copy of the final accepted paper to the NIH National Library of Medicine (NLM) and PubMed Central (PMC) on the author’s behalf in accordance with NIH guidelines. (For more information use link at top of page).

Appeal Requests

Authors who wish to request reconsideration of a rejected manuscript should contact the Editorial Office at crummery@mich.ca. Requests must include the manuscript ID (PPUL-11-0000) and a detailed description of why the authors believe the paper should be reconsidered. Please be aware that appeal requests will only be permitted for the most deserving manuscripts due to space limitations.

Appeal requests will be evaluated by the Editor-in-Chief to determine if an appeal will be permitted. If the appeal is allowed, instructions will be provided on how to resubmit your paper. Authors should not resubmit their rejected paper without prior approval from the Editors and the Editorial Office.

Please note that the Editorial Office will only consider requests sent directly to crummery@mich.ca. Requests that are sent elsewhere will not be considered.

??? Production Questions ???

Alyson Linefsky
Tel : 201-748-6723
Fax : 201-748-6052
E-mail: alinefsk@wiley.com